000			02146 a2200625 4500
005			20250514015642.0
264		0	_c20020102
008			200201s 0 0 eng d
022			_a1464-8431
040			_aNLM _beng _cNLM
100	1		_aHwang, C
245	0	0	_aProspects and limitations of recombinant poxviruses for prostate cancer immunotherapy. _h[electronic resource]
260			_bCurrent opinion in molecular therapeutics _cAug 1999
300			_a471-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
650	0	4	_aAdenocarcinoma _ximmunology
650	0	4	_aAnimals
650	0	4	_aAntibodies, Viral _ximmunology
650	0	4	_aAntigen Presentation
650	0	4	_aAntigens, Neoplasm _xgenetics
650	0	4	_aAutoimmunity
650	0	4	_aB7-1 Antigen _xgenetics
650	0	4	_aCanarypox virus _xgenetics
650	0	4	_aCancer Vaccines _xadministration & dosage
650	0	4	_aCell Compartmentation
650	0	4	_aClinical Trials as Topic
650	0	4	_aCombined Modality Therapy
650	0	4	_aCytokines _xgenetics
650	0	4	_aDNA, Recombinant _xgenetics
650	0	4	_aFowlpox virus _xgenetics
650	0	4	_aGenetic Therapy _xmethods
650	0	4	_aGenetic Vectors _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aImmunotherapy _xmethods
650	0	4	_aImmunotherapy, Active
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Transgenic
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Transplantation
650	0	4	_aPoxviridae _xgenetics
650	0	4	_aPromoter Regions, Genetic _xgenetics
650	0	4	_aProstatic Neoplasms _ximmunology
650	0	4	_aRats
650	0	4	_aRecombinant Fusion Proteins _ximmunology
650	0	4	_aSalvage Therapy
650	0	4	_aSelf Tolerance
650	0	4	_aSmallpox Vaccine _ximmunology
650	0	4	_aSpecies Specificity
650	0	4	_aVaccination
650	0	4	_aVaccinia _xgenetics
650	0	4	_aViral Vaccines _xadministration & dosage
700	1		_aSanda, M G
773	0		_tCurrent opinion in molecular therapeutics _gvol. 1 _gno. 4 _gp. 471-9
999			_c11628374 _d11628374